Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture.

Human tumor cells of the lines WiDr (adenocarcinoma of the rectosigmoid colon), NHIK 3025 (carcinoma of the cervix), and V79 Chinese hamster fibroblasts were treated with 5-aminolevulinic acid (ALA) and ALA esterified to C1-C3 and C6-C8 chained aliphatic alcohols (ALA-esters). In the human cell lines, esterification of ALA with the long-chain (C6-C8) alcohols was found to reduce 30-150-fold the amount of ALA needed to reach the same level of protoporphyrin IX (PpIX) accumulation as with non-esterified ALA. The long-chained ALA-esters were less efficient in stimulating PpIX formation in V79 cells, i.e., the same amount of PpIX was formed by a 1-2.6-fold lower concentration of long-chained ALA-esters than with ALA. Short-chained ALA-esters (C1-C3) induced 5 to 10 times lower PpIX accumulation than ALA in all of the cell lines. High-performance liquid chromatography and fluorescence microscopic studies indicated that esterification of ALA has neither impact on the fluorescing porphyrin species formed nor impact on their intracellular localization. The PpIX formed from ALA-esters and ALA was found to be equally efficient in sensitizing cells to photoinactivation. The present results indicate that esterified ALAs are new and promising drugs for use in photochemotherapy of cancer.

[1]  Z. Malik,et al.  In vivo effects of porphyrins on bacterial DNA. , 1991, Journal of photochemistry and photobiology. B, Biology.

[2]  J Moan,et al.  Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. , 1996, Journal of Photochemistry and Photobiology. B: Biology.

[3]  M. Pastor-Anglada,et al.  Regulatory and molecular aspects of mammalian amino acid transport. , 1994, The Biochemical journal.

[4]  M. Luxenberg,et al.  Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. , 1986, Ophthalmology.

[5]  H Kerl,et al.  Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.

[6]  Evidence that 4-aminobutyric acid and 5-aminolevulinic acid share a common transport system into Saccharomyces cerevisiae. , 1995, The international journal of biochemistry & cell biology.

[7]  J Moan,et al.  DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA , 1995, Photochemistry and photobiology.

[8]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[9]  S. Granick,et al.  Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. , 1975, The Journal of biological chemistry.

[10]  E. Bechara,et al.  5-Aminolevulinic acid mediates the in vivo and in vitro formation of 8-hydroxy-2'-deoxyguanosine in DNA. , 1994, Carcinogenesis.

[11]  S. Iinuma,et al.  A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. , 1994, British Journal of Cancer.

[12]  Kevin C. Smith,et al.  Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative , 1988, Lasers in surgery and medicine.

[13]  Z. Malik,et al.  Protoporphyrin biosynthesis in Melanoma B16 cells stimulated by 5‐aminolevulinic acid and chemical inducers: Characterization of photodynamic inactivation , 2007, International journal of cancer.

[14]  K. Berg,et al.  The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. , 1996, British Journal of Cancer.

[15]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[16]  M. E. Kenney,et al.  NEW PHTHALOCYANINES FOR PHOTODYNAMIC VIRUS INACTIVATION IN RED BLOOD CELL CONCENTRATES , 1994, Photochemistry and photobiology.

[17]  K Svanberg,et al.  FLUORESCENCE IMAGING AND POINT MEASUREMENTS OF TISSUE: APPLICATIONS TO THE DEMARCATION OF MALIGNANT TUMORS AND ATHEROSCLEROTIC LESIONS FROM NORMAL TISSUE , 1991, Photochemistry and photobiology.

[18]  Benjamin Ehrenberg,et al.  Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, dimethylsulfoxide (DMSO), and edetic acid disodium salt (EDTA) , 1995, Other Conferences.

[19]  E. Hovig,et al.  TETRASULFONATE AND TETRA(3-HYDROXYPHENYL)PORPHYRIN , 1988 .

[20]  Michele T. Cooper,et al.  Cutaneous phototoxic occurrences in patients receiving Photofrin® , 1990, Lasers in surgery and medicine.

[21]  M. Hermes-Lima.  How do Ca2+ and 5-aminolevulinic acid-derived oxyradicals promote injury to isolated mitochondria? , 1995, Free radical biology & medicine.

[22]  J. McCormick,et al.  Monocyte esterase deficiency in gastrointestinal cancer. , 1993, Journal of clinical pathology.

[23]  H. Dailey,et al.  Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. , 1984, The Biochemical journal.

[24]  Y. Tremblay,et al.  Single case report of prostate adenocarcinoma in a dog castrated three months previously. Morphological, biochemical, and endocrine determinations , 1984, The Prostate.

[25]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[26]  Q. Peng,et al.  5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.

[27]  J Moan,et al.  Combined treatment of ionizing radiation and photosensitization by 5-aminolevulinic acid-induced protoporphyrin IX. , 1995, Radiation Research.

[28]  C. Bloomfield,et al.  Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen. , 1988, Leukemia.

[29]  D. V. Ash,et al.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.

[30]  J Kost,et al.  Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. , 1989, The Journal of clinical investigation.

[31]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[32]  T. Puck,et al.  CLONAL GROWTH IN VITRO OF HUMAN CELLS WITH FIBROBLASTIC MORPHOLOGY , 1957, The Journal of experimental medicine.

[33]  K. Berg,et al.  Effects of the inhibitors of energy metabolism, lonidamine and levamisole, on 5‐aminolevulinic‐acid‐induced photochemotherapy , 1996, International journal of cancer.

[34]  J Moan,et al.  PHOTOCHEMOTHERAPY OF CANCER: EXPERIMENTAL RESEARCH , 1992, Photochemistry and photobiology.

[35]  M. Berns,et al.  Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative , 1984, Lasers in surgery and medicine.